Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sector movers: Cyclicals bounce back, Evraz in the lead

Wed, 01st Feb 2017 15:46

(ShareCast News) - There was a clear split in the market on Wednesday as cyclicals bounced back and the more defensive segments of the market were relegated to the bottom of the pile.Thus, shares in Prudential and Aviva were to be seen pacing gains among life insurers as yields on benchmark 10-year Gilts climbed four basis points to 1.46%.From a global perspective, risk-appetite was stoked by better-than-expected quarterly numbers out of Apple overnight and a far stronger-than-expected reading on the state of the US labour market in January.Private sector hiring in the States jumped by an outsized 246,000 in January, after a reading of 151,000 in the month before (consensus: 165,000).Nonetheless, Paul Ashworth at Capital Economics cautioned that January's very strong ADP reading might have been the result of problems adjusting for seasonal factors at the start of the year due to the way the survey is compiled.Then there was the survey's "spotty" track record over the longer-term."The upshot is that, while we wouldn't dismiss the strength of the ADP number entirely, we would treat it with some caution, particularly in January," Ashworth said,Against that backdrop, shares in Evraz were noticeably higher following their recent sideways movement.Helping sentiment, the official Chinese manufacturing sector PMI ticked lower from a reading of 51.4 in December to 51.3 (consensus: 51.2)."While recent raw materials headwinds are due to weigh on Q4 results and Q1 guidance, this near-term risk belies strong emerging steel market momentum looking through 2017. Regional steel prices remain supported by low customer inventories, uncompetitive imports and seasonally/structurally improving demand, and steelmaker margins are due to expand significantly into Q2," Seth Rosenfeld at Jefferies told clients in a research note issued the previous day.Pharma shares were also wanted following US president Trump's meeting with big pharma executives during the previous session."This "carrot and stick" approach appears to have soothed concerns that Mr Trump may have felt compelled to take a sledgehammer approach to the industry and has seen Hikma, AstraZeneca and Shire Pharmaceuticals all push higher," commented CMC Markets's chief market analyst Michael Hewson.Top performing sectors so far todayIndustrial Metals & Mining 2,472.22 +6.54%Life Insurance 7,719.83 +1.24%Automobiles & Parts 8,122.44 +1.16%Pharmaceuticals & Biotechnology 13,038.57 +1.11%Construction & Materials 6,754.82 +1.00%Bottom performing sectors so far todayBeverages 17,320.48 -0.83%Gas, Water & Multiutilities 5,876.14 -0.77%Personal Goods 28,994.00 -0.69%Electricity 8,814.94 -0.65%Tobacco 55,315.14 -0.59%
More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.